BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21255063)

  • 21. Characteristics and prognosis of chromophobe non-metastatic renal cell carcinoma: a multicenter study.
    Lee WK; Byun SS; Kim HH; Rha KH; Hwang TK; Sung GT; Lee W; Lim JS; Jeong YB; Kwon TG
    Int J Urol; 2010 Nov; 17(11):898-904. PubMed ID: 20969636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of insulin- like growth factor-I receptor expression in renal cell carcinoma.
    Sichani MM; Yazdi FS; Moghaddam NA; Chehrei A; Kabiri M; Naeimi A; Taheri D
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):69-74. PubMed ID: 20061696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological correlates and prognostic significance of glutathione S-transferase Pi expression in 468 patients after potentially curative resection of node-positive colonic cancer.
    Tan KL; Jankova L; Chan C; Fung CL; Clarke C; Lin BP; Robertson G; Molloy M; Chapuis PH; Bokey L; Dent OF; Clarke SJ
    Histopathology; 2011 Dec; 59(6):1057-70. PubMed ID: 22175886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD44s, E-cadherin and PCNA as markers for progression in renal cell carcinoma.
    Fischer C; Georg C; Kraus S; Terpe HJ; Luedecke G; Weidner W
    Anticancer Res; 1999; 19(2C):1513-7. PubMed ID: 10365135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased ARID1A expression correlates with poor prognosis of clear cell renal cell carcinoma.
    Park JH; Lee C; Suh JH; Chae JY; Kim HW; Moon KC
    Hum Pathol; 2015 Mar; 46(3):454-60. PubMed ID: 25628030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The significance of thymidine phosphorylase/platelet-derived endothelial cell growth factor activity in renal cell carcinoma.
    Mizutani Y; Wada H; Yoshida O; Fukushima M; Kawauchi A; Nakao M; Miki T
    Cancer; 2003 Aug; 98(4):730-6. PubMed ID: 12910516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glutathione S-transferase isoenzyme profile in non-tumor and tumor human kidney tissue.
    Simić T; Mimić-Oka J; Ille K; Dragicević D; Savić-Radojević A
    World J Urol; 2003 May; 20(6):385-91. PubMed ID: 12811499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis.
    Uhlman DL; Nguyen P; Manivel JC; Zhang G; Hagen K; Fraley E; Aeppli D; Niehans GA
    Clin Cancer Res; 1995 Aug; 1(8):913-20. PubMed ID: 9816062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered antioxidant capacity in human renal cell carcinoma: role of glutathione associated enzymes.
    Pljesa-Ercegovac M; Mimic-Oka J; Dragicevic D; Savic-Radojevic A; Opacic M; Pljesa S; Radosavljevic R; Simic T
    Urol Oncol; 2008; 26(2):175-81. PubMed ID: 18312938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activated extracellular signal-regulated kinase is an independent prognostic factor in clinically confined renal cell carcinoma.
    Campbell L; Nuttall R; Griffiths D; Gumbleton M
    Cancer; 2009 Aug; 115(15):3457-67. PubMed ID: 19526593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma.
    Roos FC; Weirich J; Victor A; Elsässer A; Brenner W; Biesterfeld S; Hampel C; Thüroff JW
    BJU Int; 2009 Aug; 104(4):461-9. PubMed ID: 19338563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High levels of thymidine phosphorylase as an independent prognostic factor in renal cell carcinoma.
    Takayama T; Mugiya S; Sugiyama T; Aoki T; Furuse H; Liu H; Hirano Y; Kai F; Ushiyama T; Ozono S
    Jpn J Clin Oncol; 2006 Sep; 36(9):564-9. PubMed ID: 16861722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C; Song C; Hong JH; Kim CS; Ahn H
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of primary renal carcinoma cultures.
    Sievers E; Dreimuller P; Haferkamp A; Schmidt-Wolf IG; Buchler MW; Schmidt J; Marten A
    Urol Int; 2007; 79(3):235-43. PubMed ID: 17940356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma.
    Riesenberg R; Weiler C; Spring O; Eder M; Buchner A; Popp T; Castro M; Kammerer R; Takikawa O; Hatz RA; Stief CG; Hofstetter A; Zimmermann W
    Clin Cancer Res; 2007 Dec; 13(23):6993-7002. PubMed ID: 18056175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of nuclear p27(kip1) and α-dystroglycan is a frequent event and is a strong predictor of poor outcome in renal cell carcinoma.
    Sgambato A; Camerini A; Genovese G; De Luca F; Viacava P; Migaldi M; Boninsegna A; Cecchi M; Sepich CA; Rossi G; Arena V; Cittadini A; Amoroso D
    Cancer Sci; 2010 Sep; 101(9):2080-6. PubMed ID: 20626751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma.
    Meyer HA; Tölle A; Jung M; Fritzsche FR; Haendler B; Kristiansen I; Gaspert A; Johannsen M; Jung K; Kristiansen G
    Eur Urol; 2009 Mar; 55(3):669-78. PubMed ID: 18450365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
    Larsson P
    Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclooxygenase-2 expression and relationship to tumour progression in human renal cell carcinoma.
    Hashimoto Y; Kondo Y; Kimura G; Matsuzawa I; Sato S; Ishizaki M; Imura N; Akimoto M; Hara S
    Histopathology; 2004 Apr; 44(4):353-9. PubMed ID: 15049901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hybrid renal cell carcinomas containing histopathologic features of chromophobe renal cell carcinomas and oncocytomas have excellent oncologic outcomes.
    Waldert M; Klatte T; Haitel A; Ozsoy M; Schmidbauer J; Marberger M; Remzi M
    Eur Urol; 2010 Apr; 57(4):661-5. PubMed ID: 19477583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.